For the Inventor, By the Inventor

Enter assignee name

Houston, TX, United States of America

Tanox, Inc.

USPTO Granted Patents = 31

% Expired Patents = 19.4

CIPO Patents = 4

EPO Patents = 3

Trademarks = 1

Forward Citations = 610

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Michael C Kiefer (6 out of 43 patents)

Cecily R Y Sun (6 out of 24 patents)

Michael S C Fung (6 out of 14 patents)

4. Philip J Barr (5 out of 67 patents)

5. Nancy T Chang (5 out of 22 patents)

6. Tse Wen Chang (5 out of 5 patents)

7. Sanjaya Singh (4 out of 71 patents)

8. Herren Wu (4 out of 50 patents)

9. Catherine Foster (4 out of 4 patents)

10. Tse W Chang (4 out of 32 patents)

11. William N C Sun (3 out of 15 patents)

12. Bill N C Sun (3 out of 9 patents)

13. Hovsep S Melkonyan (3 out of 7 patents)

14. Samuil R Umansky (3 out of 8 patents)

15. David R Thomas (2 out of 28 patents)

Core Competencies:

Anti-Human IgE Antibodies

Apoptosis-Modulating Proteins

Complement Activation Inhibitors

Bispecific Molecules

Therapeutic Agents

Chimeric Monoclonal Antibodies

HIV-1 Neutralization

T Lymphocytes

CpG Oligonucleotides

Bak Binding Protein

Immune Modulators

ADCC Enhancement

31 patents: Sort by Forward Citations

1. 9156908 - High affinity, anti-human IgE antibodies (2015-10-13),

2. 8604171 - High affinity, anti-human IgE antibodies (2013-12-10),

3. 8252284 - High affinity, anti-human IgE antibodies (2012-08-28),

4. 7531169 - High affinity anti-human IgE antibodies (2009-05-12),

5. 7316915 - Bak binding protein, DNA encoding the protein, and methods of use thereof (2008-01-08),

6. 7118743 - Bispecific molecules cross-linking ITIM and ITAM for therapy (2006-10-10),

7. 7112327 - Inhibition of complement activation (2006-09-26),

8. 7108989 - Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof (2006-09-19),

9. 7045604 - Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof (2006-05-16),

10. 7045596 - Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof (2006-05-16),

11. 6998468 - Anti-C2/C2a inhibitors of complement activation (2006-02-14),

12. 6956107 - Inhibitors of complement activation (2005-10-18),

13. 6903195 - Methods and compositions for detecting CDN apoptosis-modulating proteins (2005-06-07),

14. 6787524 - CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies (2004-09-07),

15. 6767540 - Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease (2004-07-27),

Tanox, Inc. is a biotechnology company based in Houston, Texas, specializing in the development of innovative therapeutic solutions. The organization focuses on research and technology in the fields of immunology and allergy treatment, particularly targeting conditions such as asthma and allergic diseases. Tanox is dedicated to advancing its proprietary technologies to improve patient outcomes and enhance the understanding of immune responses, contributing to the broader landscape of biopharmaceutical advancements.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

31 Patents

#165 in Houston, TX

#599 in Texas

#10,921 in US

#21,238 in the World

Houston, TX, United States of America

Tanox, Inc.

Forward Citations = 610

30 inventors:

Michael C Kiefer (6 out of 43 patents)

Cecily R Y Sun (6 out of 24 patents)

Michael S C Fung (6 out of 14 patents)

4. Philip J Barr (5 out of 67 patents)

5. Nancy T Chang (5 out of 22 patents)

Please report any incorrect information to [email protected]

Loading…